Biontech to present clinical data updates across mrna and immunomodulatory oncology portfolio at esmo congress 2024

Mainz, germany, september 05, 2024 – biontech se (nasdaq: bntx, “biontech” or “the company”) will present clinical trial data for selected assets from its multi-platform oncology pipeline at the european society for molecular oncology (“esmo”) congress 2024 in barcelona, spain from september 13-17, 2024. the oral and poster presentations will feature programs across biontech's clinical pipeline, including mrna-based cancer vaccines, next-generation immunomodulators and targeted therapy approaches.
BNTX Ratings Summary
BNTX Quant Ranking